C93.00
Acute monoblastic/monocytic leukemia, not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Acute monoblastic/monocytic leukemia with failed remission
- Acute monoblastic/monocytic leukemia NOS
Medical Intelligence & Overview
Acute monoblastic/monocytic leukemia is a type of blood cancer that affects the white blood cells. Specifically, it involves an overproduction of abnormal monoblastic or monocytic cells, which are immature forms of monocytes—a type of immune cell. When the disease is classified as not having achieved remission, it indicates that previous treatment has not successfully eliminated the cancer, and the disease persists. This form of leukemia is aggressive and requires specialized medical care to manage.
Causes & Symptoms
Clinical Causes: Genetic mutations or abnormalities in blood-forming cells Exposure to certain chemicals or radiation Previous chemotherapy or radiation therapy Inherited genetic syndromes Environmental factors that may alter DNA in bone marrow cells
Key Symptoms: Unexplained weight loss Persistent fever or infections Fatigue and weakness Bone or joint pain Ease of bruising or bleeding Swelling of the lymph nodes or spleen Shortness of breath
Diagnostic & Treatment
Diagnosis Path: Diagnosing acute monoblastic/monocytic leukemia involves several steps, including blood tests and bone marrow examination. Typically, these assessments reveal abnormal monoblastic or monocytic cells in the blood or bone marrow. Additional tests, such as immunophenotyping and genetic studies, may be performed to understand the specific characteristics of the leukemia and guide treatment options. The diagnosis must confirm that the disease has not achieved remission after previous therapies, indicating ongoing active disease.
Treatment Protocols: Treatment strategies for this type of leukemia often involve chemotherapy to kill the cancerous cells. In cases where remission has not been achieved, more aggressive or alternative therapies may be considered. These can include targeted therapy, stem cell transplantation, or clinical trial enrollment. Supportive care is also essential to manage symptoms and prevent infections. Because this condition is complex and requires specialized care, treatment is typically coordinated by a team of hematologists and oncologists.
Clinical Advice & FAQs
Billing Guidance
Is C93.00 a billable ICD-10 code?
Yes, C93.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C93.00?
Clinical documentation must specify the nature of Acute monoblastic/monocytic leukemia, not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
